With Closer Eye On Indian Units, U.S. FDA Names Altaf Lal As New Country Director
This article was originally published in PharmAsia News
Executive Summary
Four years after it established its first India base, U.S. FDA has effected a leadership change. The new chief is expected to play a double role as both guide and vigilant examiner.
You may also be interested in...
Merck JV Ties Up With MEND To Focus On First Heat-stable Rotavirus Vaccine For Developing Markets
MUMBAI - Hilleman Laboratories - the nonprofit joint venture between Merck & Co. and Wellcome Trust to develop affordable vaccines for low-income countries - has set its sights on developing a heat-stable form of rotavirus vaccine as its first project
U.S. FDA Readies India Staffing; Says India Office To Enhance Speed And Effectiveness Of Regulatory Cooperation
MUMBAI - U.S. FDA has hand picked a few top notch professionals from its global headquarters for positions at the newly planned Mumbai and New Delhi offices. Over the years, these officers have gained experience in drug regulation and investigations through several global postings
Indian Investors Turn Cautious On Compliance Concerns
A rising number of enforcement actions by major drug regulators like the U.S. FDA is slowly making investors cautious about the longer term repercussions on earnings of Indian drug makers.